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Introduction
DNA double-stranded breaks (DSBs) are among the most dan-
gerous forms of DNA damage. Unrepaired DSBs signal cells   
to die, whereas misprocessing of DSBs can lead to genomic 
instability and oncogenic transformation. DSBs are primar-
ily repaired by the nonhomologous end-joining (NHEJ) and   
homologous recombination (HR) repair pathways. The NHEJ 
pathway joins the two ends of a DSB directly with little or no 
requirement for homology, whereas HR uses the intact identical 
copy of the broken chromosome as a template. Although both 
NHEJ and HR proteins are recruited to DSBs, pathway choice 
is regulated in part by the cell cycle phase, with HR being active 
in S/G2 and NHEJ contributing to DSB repair predominantly   
in G0/G1. For example, V(D)J (variable [diversity] joining)   
recombination-associated breaks are generated in G0/G1 and 
resolved by NHEJ proteins, whereas meiotic DSBs are pro-
cessed by HR proteins. Nevertheless, a recent study indicates 
competition between HR and NHEJ for replication- and ioniz-
ing radiation (IR)–induced DSBs during the S and G2 phase of 
the cell cycle (Sonoda et al., 2006).
T
he  nonhomologous  end-joining  (NHEJ)  pathway   
is essential for radioresistance and lymphocyte- 
specific V(D)J (variable [diversity] joining) recombi-
nation. Defects in NHEJ also impair hematopoietic stem 
cell (HSC) activity with age but do not affect the initial   
establishment of HSC reserves. In this paper, we report that, 
in  contrast  to  deoxyribonucleic  acid  (DNA)–dependent 
protein  kinase  catalytic  subunit  (DNA-PKcs)–null  mice, 
knockin mice with the DNA-PKcs
3A/3A allele, which codes 
for three alanine substitutions at the mouse Thr2605 phos-
phorylation cluster, die prematurely because of congenital 
bone marrow failure. Impaired proliferation of DNA-
PKcs
3A/3A HSCs is caused by excessive DNA damage and 
p53-dependent apoptosis. In addition, increased apopto-
sis in the intestinal crypt and epidermal hyperpigmenta-
tion indicate the presence of elevated genotoxic stress and 
p53 activation. Analysis of embryonic fibroblasts further 
reveals that DNA-PKcs
3A/3A cells are hypersensitive to 
DNA  cross-linking  agents  and  are  defective  in  both   
homologous recombination and the Fanconi anemia DNA 
damage response pathways. We conclude that phosphory-
lation of DNA-PKcs is essential for the normal activation 
of multiple DNA repair pathways, which in turn is critical 
for the maintenance of diverse populations of tissue stem 
cells in mice.
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strategy (Bunting et al., 1999). The ACN cassette, including a 
testes-specific tACE promoter-driven Cre recombinase, a Neo-
selectable marker, and two flanking loxP sites, was fused with 
two genomic fragments with the longer fragment carrying mu-
tated exon 58 (covering the entire mouse Thr2605 cluster) in 
close proximity to the ACN cassette (Fig. 1 B). Upon successful 
gene targeting and subsequent germline transmission in chime-
ric mice, expression of Cre recombinase during spermatogenesis 
self-excises the ACN cassette. This process leaves behind one 
remaining loxP site and allows the expression of the 3A mutant 
DNA-PKcs from the targeted allele. Using this strategy, two 
knockin mouse lines were generated from two independently 
targeted embryonic stem (ES) cell clones. Analyses of mice and 
cultured cells yielded identical phenotypes from both lines.
Alanine substitutions at all three threonine sites (Thr2605, 
Thr2634, and Thr2643) of the targeted allele were confirmed by 
sequencing DNA isolated from tails of heterozygotic (DNA-
PKcs
+/3A) carriers. The sequencing profile showed equal detec-
tion of A from the wild-type allele and G from the targeted allele 
at all three mutated positions (Fig. S1 A). The 3A substitution and 
The DNA-dependent protein kinase (DNA-PK) consists 
of  the  large  catalytic  subunit  (DNA-PK  catalytic  subunit   
[DNA-PKcs]) and the DNA-binding Ku70/80 heterodimer. The 
DSB is initially recognized by DNA-PK. The ends are then 
synapsed and processed by other NHEJ proteins, including 
Artemis, XLF, and XRCC4, before they are ligated together by 
ligase IV (Weterings and Chen, 2008). DNA-PKcs belongs to a 
serine/threonine protein kinase family known as the phosphati-
dylinositol-3 kinase–like protein kinases. Family members   
include  ataxia  telangiectasia  mutated  (ATM)  and ATM-  and 
Rad3-related (ATR) kinases (Shiloh, 2003). DNA-PKcs, itself, 
is essential for NHEJ-mediated DSB repair, and loss of the 
DNA-PKcs protein leads to radiation hypersensitivity as well as 
severe combined immunodeficiency (SCID) caused by a block 
in V(D)J recombination. In addition, DNA-PKcs deficiency re-
sults in a defect in immunoglobulin class switch recombination 
(Manis et al., 2002; Cook et al., 2003; Callén et al., 2009). 
DNA-PKcs is phosphorylated in several regions in vitro upon 
activation and in vivo upon treatment with IR (Chan et al., 2002; 
Douglas et al., 2002; Chen et al., 2005; Ma et al., 2005; Meek   
et al., 2007). IR-induced Ser2056 phosphorylation is mediated 
by DNA-PKcs autophosphorylation, as it is significantly re-
duced in a kinase-dead mutant DNA-PKcs and is inhibited by 
the DNA-PKcs kinase inhibitor (Chen et al., 2005). In contrast, 
DNA-PKcs phosphorylation at the Thr2609 cluster is depen-
dent on ATM and ATR kinases in response to IR and UV radia-
tion, respectively (Yajima et al., 2006; Chen et al., 2007). 
DNA-PKcs phosphorylation at either the Thr2609 cluster or at 
Ser2056 does not affect its kinase activity; nevertheless, abroga-
tion of DNA-PKcs phosphorylation at either region attenuates 
DSB repair and leads to increased radiosensitivity (Chan et al., 
2002; Ding et al., 2003; Chen et al., 2005, 2007).
To gain insight into the physiological significance of phos-
phorylation at this cluster, we have generated a 3A knockin 
mouse model, in which the three threonine residues are substi-
tuted with alanines. In this study, we report that DNA-PKcs
3A/3A 
mice  surprisingly  develop  congenital  hematopoietic  failure 
caused by rapid loss of hematopoietic stem cells (HSCs) in the 
developing fetal liver. This severe hematopoietic phenotype was 
attributed to a compound deficiency in DSB repair, including the 
HR and Fanconi anemia (FA) pathways. Because being defective 
in NHEJ alone does not block HSC expansion in the embryo, we 
conclude that the HR/FA pathways are essential for HSC devel-
opment  and  that  DNA-PKcs  phosphorylation  at  the Thr2609 
cluster is a prerequisite for the pathway switch favoring HR/FA.
Results
Generation of a DNA-PKcs
3A knockin 
mouse model
Our knockin mouse model of DNA-PKcs harbors three alanine 
substitutions at Thr2605, Thr2634, and Thr2643 (3A mutation, 
corresponding to human Thr2609, Thr2638, and Thr2647) of the 
endogenous mouse DNA-PKcs or PRKDC gene locus (Fig. 1 A). 
The design of the 3A knockin targeting vector was based on a 
previously described self-excision ACN (testes-specific angio-
tensin-converting enzyme [tACE]–Cre/neomycin [Neo]) cassette 
Figure 1.  Generation of a DNA-PKcs
3A/3A knockin mouse model. (A) The 
alignment of the human Thr2609 and the mouse Thr2605 phosphorylation 
cluster of DNA-PKcs. Six phosphorylation sites were identified in the human 
Thr2609 cluster (highlighted with asterisks), which are highly conserved in 
the mouse except for Ser2624. Boxes indicate the positions of knockin mu-
tations or alanine substitutions. (B) Strategy to introduce knockin mutations 
into a mouse ES cell. 58*, exon 58 with T2605A, T2634A, and T2643A 
mutations;  tACE-Cre,  Cre  recombinase  driven  by  a  tACE  promoter.   
(C) 3A mutation does not alter the expression of DNA-PKcs. Whole-cell 
lysates from different MEFs were analyzed for the expression of DNA-PKcs, 
Ku70/80,  and  -actin.  (D)  DNA-PKcs
3A/3A  MEFs  are  hypersensitive  to   
radiation (representative of three independent assays). Error bars represent 
SD. (E) Survival curves generated by Kaplan–Meier analysis (curves were 
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(Gao et al., 1998; Taccioli et al., 1998; Kurimasa et al., 1999). 
Like DNA-PKcs
/ mice, the number of lymphocytes and the 
size of lymphoid organs were drastically attenuated in 2-wk-old 
DNA-PKcs
3A/3A mice (Fig. 2 A and Fig. S2 A). In contrast to the 
early T cell development block at the CD4
CD8
 double-negative 
stage in DNA-PKcs–null mice (Gao et al., 1998; Kurimasa et al., 
1999), DNA-PKcs
3A/3A mice have CD4
+CD8
+, CD4
+CD8
, and 
CD4
CD8
+  thymocytes,  although  at  significantly  reduced 
numbers (Fig. 2, A and B). Analyses of thymocyte subsets also 
reveal a severe reduction of DNA-PKcs
3A/3A double-negative 
thymocytes  at  different  developmental  stages  (Fig.  S2  B). 
Moreover, there is a significant reduction in the numbers of   
T cells expressing TCR-/ (Fig. S2 C) and TCR- (Fig. S2 D), 
which is observed in mice with mutations that cause a subtotal 
block in V(D)J recombination (Difilippantonio et al., 2008). 
Nevertheless, single-positive splenic T cells accumulated in the 
DNA-PKcs
3A/3A spleen (Fig. 2 C). B cell development in DNA-
PKcs
3A/3A mice was also dramatically affected, with an appar-
ent arrest at the B220
lowCD43
+IgM
 (pro-B cell) stage in bone 
marrow and few mature B cells in the spleen (Fig. 2 D), which 
is similar to the defective B cell development in DNA-PKcs
/ 
mice (Gao et al., 1998; Taccioli et al., 1998; Kurimasa et al., 
1999). Significant loss of nucleotides is a hallmark of coding 
joint formation in DNA-PKcs–deficient mice, and we find that 
the extent of nucleotide loss during coding joint formation in 
DNA-PKcs
3A/3A  thymocytes  is  similar  to  that  observed  in 
DNA-PKcs–deficient (SCID) thymocytes (Fig. 2 E, Fig. S2 E, 
Table S1, Table S2, and Table S3). Thus, phosphorylation   
of the Thr2605 cluster in DNA-PKcs is required for normal 
V(D)J recombination.
the one remaining loxP site between exon 58 and exon 59 did 
not affect the expression of the 3A mutant DNA-PKcs from the 
targeted allele, as similar levels of the DNA-PKcs protein were 
detected in mouse embryonic fibroblasts (MEFs) derived from 
all genotypes (Fig. 1 C). The 3A substitution also did not affect 
the kinase activity of DNA-PKcs (Fig. S1 D) as previously   
reported (Ding et al., 2003; Chen et al., 2007). Nonetheless, 
clonogenic survival analysis revealed that DNA-PKcs
3A/3A MEFs 
were hypersensitive to IR to a similar degree as DNA-PKcs–null 
MEFs (Fig. 1 D).
Complete disruption of the mouse DNA-PKcs gene results 
in an SCID phenotype (Gao et al., 1998; Taccioli et al., 1998; 
Kurimasa et al., 1999), but in contrast to Ku-deficient mice, 
there is no apparent growth retardation, infertility, or life short-
ening in DNA-PKcs
/ mice (Nussenzweig et al., 1996; Gu   
et al., 1997; Ouyang et al., 1997). Homozygous DNA-PKcs
3A/3A 
mice were born at the expected Mendelian frequency with simi-
lar  body  weight  to  littermates,  but  they  became  apparently 
smaller within 2–3 wk of age (Fig. S1 C). In striking contrast to 
the normal life span of control, heterozygous littermates, and 
DNA-PKcs
/ mice, the great majority of DNA-PKcs
3A/3A mice 
died shortly after birth (Fig. 1 E). In a cohort of 56 DNA-PKcs
3A/3A 
mice, 75% died within 4 wk of birth, and only one mouse sur-
vived >12 wk.
Lymphocyte hypoplasia and the  
V(D)J recombination defect in  
DNA-PKcs
3A/3A mice
Lymphocyte development in DNA-PKcs–null mice is severely 
compromised  because  of  a  block  in V(D)J  recombination 
Figure  2.  Lymphocyte  development  in  DNA-PKcs
3A/3A 
mice. (A) T and B cell numbers are drastically reduced 
in 2-wk-old DNA-PKcs
3A/3A mice. n = 4. Error bars rep-
resent  SD.  (B)  Flow  cytometric  analysis  of  thymocytes 
from 2-wk-old mice. Similar to wild-type cells, the major-
ity  of  DNA-PKcs
3A/3A  thymocytes  were  double  positive 
(CD4
+CD8
+).  However,  single-positive  cell,  particularly 
CD4
+CD8
, thymocytes were reduced in DNA-PKcs
3A/3A 
mice. (C) Flow cytometric analysis of splenocytes from   
2-wk-old mice. Single-positive CD4
+CD8
 and CD4
CD8
+ 
T cells were present in the DNA-PKcs
3A/3A spleen, but 
the  numbers  were  also  reduced.  The  numbers  indi-
cate the percentages of cell counts to total population 
in each quadrant. The lines separate the negative and 
the  positive  cell  populations  in  each  FACS  analysis.   
(D) Flow cytometric analysis of B lymphocyte develop-
ment. B cell development in DNA-PKcs
3A/3A mice was 
arrested at the pro-B cell (B220
lowCD43
+IgM
) stage with 
very few mature B cells. Boxes indicate pro-B cell gate 
(B220
lowCD43
+IgM
);  numbers  indicate  percentages 
of cells in the gate to total population. (E) Analysis of 
the mean number of junctional nucleotides lost in D2:
J1 coding joints cloned and sequenced from wild-type, 
SCID, and DNA-PKcs
3A/3A thymocytes. Means ± SEM are 
plotted for each genotype. Results from two mice were 
pooled for each genotype. Primary data are shown in 
Table S1, Table S2, and Table S3. (F) Side scatter (SSC) 
and forward scatter (FSC) signal of bone marrow (BM) 
cells in flow cytometric analysis. Data show that, in the 
DNA-PKcs
3A/3A bone marrow, not only in the lymphoid (L) 
gate but also in the granulocyte and macrophage (G/M) 
gate, cell number dropped to a very low level compared 
with wild-type and knockout (KO) mice.JCB • VOLUME 193 • NUMBER 2 • 2011   298
difference was found in wild type, DNA-PKcs
+/3A mice (Fig. 3 E), 
or in DNA-PKcs
/ mice (Fig. 3 D). These results demonstrate 
that there is an impaired maintenance or self-renewal of bone 
marrow HSCs in DNA-PKcs
3A/3A mice and that the initiation   
of HSC pathogenesis occurs during embryonic development. 
Importantly, this dramatic early HSC failure has not been ob-
served in other NHEJ-deficient mouse strains, in which HSC 
reserves are generally preserved in young mice (Nijnik et al., 
2007; Rossi et al., 2007).
Fetal liver HSC dysfunction and loss in 
DNA-PKcs
3A/3A mice
The fetal liver is known to be the main source of hematopoiesis 
during embryonic development, as it provides supportive niches 
for HSC expansion and maturation (Mikkola and Orkin, 2006). 
To determine when HSC homeostasis dysfunction occurred in 
DNA-PKcs
3A/3A embryos, fetal liver samples from different de-
velopmental stages were harvested and analyzed. Flow cyto-
metric analysis revealed a decreased number of fetal liver LSK 
cells in DNA-PKcs
3A/3A embryos at embryonic day (E) 14.5 
(0.08 ± 0.04% vs. wild type 0.19 ± 0.06%) and E.16.5 (0.05 ± 
0.02% vs. wild type 0.14 ± 0.02%; Fig. 4, A and B). At E12.5, 
the  LSK  cell  population  in  DNA-PKcs
3A/3A  embryos  was 
slightly reduced (0.23 ± 0.10%) but remained within the nor-
mal range of wild-type embryos (0.26 ± 0.11%; Fig. 4 B). Sig-
nificantly, the depletion of HSC reserves in the DNA-PKcs
3A/3A 
fetal liver occurs when HSCs are highly proliferative and   
undergo rapid expansion (Mikkola and Orkin, 2006). To examine 
whether the HSC loss in DNA-PKcs
3A/3A mice was a result of 
defective cell proliferation, freshly isolated fetal liver LSK 
cells were cultured for ex vivo expansion. Wild-type and DNA-
PKcs
+/3A LSK cells proliferated exponentially and continuously 
during the course of ex vivo expansion, whereas DNA-PKcs
3A/3A 
LSK cells proliferated normally only in the first 24 h (Fig. 4 C). 
The expansion of DNA-PKcs
3A/3A LSK cells slowed down at 48 h 
and then collapsed at 72 h as a result of massive cell death (un-
published data).
Congenital bone marrow failure and HSC 
loss in DNA-PKcs
3A/3A mice
Although lymphocyte development is compromised in DNA-
PKcs
3A/3A mice, this would not be expected to cause early post-
natal lethality in DNA-PKcs
3A/3A mice, as SCID mice live a 
normal life span. Examination of forward angle versus side   
angle light scatter plots in bone marrow revealed not only a deple-
tion of cells in the lymphocyte gate (as in SCID mice) but also 
a lack of cells in the granulocyte and macrophage gate in DNA-
PKcs
3A/3A bone marrow with a characteristically high level of 
side scatter, suggesting a more general loss of leukocytes (Fig. 2 F). 
During our investigation, we noticed that the ears, paws, and   
internal organs of DNA-PKcs
3A/3A mice were pale, suggesting the 
development of anemia. A complete peripheral blood cell count 
in 2-wk-old mice revealed a significant reduction in the num-
bers of WBCs, RBCs, and platelets in DNA-PKcs
3A/3A mice, 
suggesting the development of multilineage peripheral blood 
cytopenia  (Table  S4). Analysis  of  peripheral  blood  samples 
taken at different time points showed that pancytopenia in DNA-
PKcs
3A/3A mice began 2 wk after birth and worsened with age   
(Fig. 3, A and B). Consistent with the pancytopenia phenotype, 
the average number of bone marrow–nucleated cells in 2-wk-
old DNA-PKcs
3A/3A mice was significantly reduced (Fig. 3 C). 
These results suggest that depletion of bone marrow–nucleated 
cells in DNA-PKcs
3A/3A mice leads to pancytopenia, which has 
not been observed in DNA-PKcs
/ or SCID mice.
Peripheral blood cells are continuously replenished from 
HSC pools in hematopoietic organs, particularly in postnatal 
bone marrow (Kondo et al., 2003). To examine whether a defect 
in HSC homeostasis was the cause of bone marrow depletion in 
DNA-PKcs
3A/3A  mice,  a  population  of  bone  marrow  HSCs 
(Lin
Sca-1
+c-Kit
+, hereafter referred to as LSK cells) was eval-
uated by flow cytometric analysis (Morrison et al., 1995). The 
experiments revealed that bone marrow LSK cells and their de-
rivative Lin
Sca-1
c-Kit
+ progenitor cells were almost ablated 
in 2-wk-old DNA-PKcs
3A/3A mice and were 100 times less than 
wild type even at day 1 (Fig. 3, D and E), whereas no significant 
Figure  3.  Congenital  bone  marrow  failure 
and  HSC/progenitor  cell  depletion  in  DNA-
PKcs
3A/3A mice. (A) The averages of peripheral 
blood WBC counts at day 1 (D1) and day 14 
(D14) after birth (n = 4 for each group). (B) The 
averages  of  RBC  counts  reveal  the  develop-
ment of anemia in DNA-PKcs
3A/3A mice after 
birth (n = 4 for each group). (C) Bone marrow 
was  depleted  in  DNA-PKcs
3A/3A  mice.  Bone 
marrow was taken from one femur and one 
tibia of 2-wk-old mice (n = 3 for each group). 
Error bars represent SD. (D) Flow cytometric 
analysis of HSC-enriched LSK cells. Bone mar-
row cells were stained with a lineage marker 
cocktail, c-Kit, and Sca-1. LSK cells (Lin
Sca-
1
+c-Kit
+) and myeloid progenitor cells (Lin
Sca-
1
c-Kit
+)  were  ablated  in  2-wk-old  (day  14) 
DNA-PKcs
3A/3A mice. In newborn mice (day 1), 
myeloid progenitor cells were detected. Boxes 
indicate the LSK cell gate (Lin
Sca-1
+c-Kit
+).   
(E) Quantification of flow cytometric analysis 
of HSCs (n ≥ 3 for each group). Lines indicate 
the means for each group.299 Hematopoietic failure in DNA-PKcs mutant mice • Zhang et al.
performed  in  irradiated  CD45.1-recipient  mice  transplanted 
with fetal liver LSK cells from wild-type or DNA-PKcs
3A/3A 
embryos (CD45.2 background) as well as the competing wild-type 
CD45.1 bone marrow cells. As shown in Fig. 4 F, DNA-PKcs
3A/3A 
fetal liver LSKs were completely unable to repopulate in vivo, 
demonstrating the severity of hematopoietic impairment in 
DNA-PKcs
3A/3A mice. In contrast, bone marrow cells from   
8-mo-old DNA-PKcs
/ mice retained the reconstitution abil-
ity, though with a reduced potential compared with age-matched 
wild-type bone marrow cells (Fig. 4 G), suggesting a possible 
age-associated defect in hematopoiesis in DNA-PKcs
/ mice 
as also observed in other NHEJ-defective mice (Nijnik et al., 
2007; Rossi et al., 2007).
Increase of spontaneous DNA lesions  
and apoptosis in DNA-PKcs
3A/3A fetal  
liver HSCs
Based on our results, we hypothesized that the 3A mutant DNA-
PKcs might interfere with endogenous DSB repair, resulting in 
an increase of spontaneous DNA lesions and cell death. To in-
vestigate this possibility, freshly isolated LSK cells from E12.5 
fetal livers were stained for -H2AX nuclear foci, a commonly 
used surrogate marker of DSB formation. LSK cells isolated 
from wild-type and heterozygotic embryos rarely displayed   
-H2AX foci, and no more than five -H2AX foci were ob-
served in individual wild-type cells, whereas the majority of 
DNA-PKcs
3A/3A LSK cells were positively stained with -H2AX, 
and >30% contained more than five -H2AX foci (Fig. 5 A).   
In addition, a single-cell comet assay performed under alka-
line conditions also revealed that a significant portion of DNA-
PKcs
3A/3A LSK cells contained the comet tail as compared 
with that of wild-type and heterozygotic LSK cells (Fig. S4 A). 
Consistent with the induction of spontaneous DNA lesions, an 
Bone marrow transplantation rescues 
DNA-PKcs
3A/3A mice
Defective HSC expansion in fetal liver and depletion of nucle-
ated cells in postnatal bone marrow suggest that HSC failure 
might be the cause of early lethality in DNA-PKcs
3A/3A mice. To 
test this hypothesis, bone marrow transplantation (BMT) was 
performed  in  2-wk-old  DNA-PKcs
3A/3A–recipient  mice  using 
wild-type littermates as donors. BMT was performed without 
preconditioning procedures because DNA-PKcs
3A/3A mice are 
highly sensitive to radiation treatment (unpublished data) and 
are immunoincompetent. After transplantation with wild-type 
bone marrow cells, DNA-PKcs
3A/3A recipients had an 80% sur-
vival rate at 2 mo and 60% at 1 yr (Fig. 4 D). BMT-rescued 
DNA-PKcs
3A/3A mice gained weight normally compared with 
their heterozygotic littermates (Fig. S3 B). 8 wk after transplan-
tation, peripheral blood cell counts in recipient mice showed a 
complete recovery from pancytopenia and the restoration of the 
bone marrow HSC pool (Fig. S3 A). Importantly, PCR genotyp-
ing  revealed  that  hematopoietic  organs  in  DNA-PKcs
3A/3A  
recipients were reconstituted primarily by wild-type donor cells 
(Fig. 4 E), indicating a successful hematopoietic reconstitution. 
The rescue of DNA-PKcs
3A/3A mice could also be achieved by 
transplantation with bone marrow LSK cells from wild-type 
littermates with a reduced efficiency (Fig. 4 D), as the LSK fac-
tion primarily contains the upstream HSCs. In contrast, bone 
marrow contains HSCs, progenitors, and partially differentiated 
progenitors for different hematopoietic lineages and is able to 
achieve a significant rescue within a shorter window of oppor-
tunity than LSKs.
The success of BMT rescue confirmed that HSC failure is 
the main cause of early lethality in DNA-PKcs
3A/3A mice. To de-
termine whether there is an intrinsic defect of DNA-PKcs
3A/3A 
HSC proliferation in vivo, competitive repopulating assays were 
Figure  4.  Loss  of  fetal  liver  HSCs  in  DNA-PKcs
3A/3A  
embryos. (A) Flow cytometric analysis of HSC-enriched LSK 
cells in the E16.5 fetal liver. Percentages of LSKs are indi-
cated. Boxes indicate the LSK cell gate (Lin
Sca-1
+c-Kit
+). 
(B) Quantitative analysis of fetal liver LSKs. Data show 
progressive LSK loss in DNA-PKcs
3A/3A embryos (one dot 
represents one sample; at least four samples from one 
time point were analyzed for each genotype). Lines indi-
cate the means for each group. (C) Ex vivo expansion of 
E13.5 fetal liver LSK cells. DNA-PKcs
3A/3A LSKs showed 
limited  proliferation  capacity  compared  with  wild-type 
and DNA-PKcs
+/3A LSKs. (n = 3 for each group). (D) Kaplan– 
Meier  survival  curves  for  untreated  DNA-PKcs
3A/3A 
mice, bone marrow–transplanted (BMT) DNA-PKcs
3A/3A 
mice,  and  LSK  cell–transplanted  DNA-PKcs
3A/3A  mice   
(*, P < 0.05; **, P < 0.001; log-rank test). (E) Hematopoi-
etic reconstitution in DNA-PKcs
3A/3A BMT mice by donor 
cells. DNA samples from the thymus (T), spleen (S), and 
bone marrow (B) of DNA-PKcs
3A/3A BMT mice were PCR 
genotyped. Wild-type PCR products were predominantly 
presented in all three tissues. The asterisk denotes a   
517-bp  band  of  the  1-kb  DNA  ladder  (Invitrogen).   
(F) Competitive repopulation assay using E13.5 fetal liver 
cells. DNA-PKcs
3A/3A HSCs (CD45.1
CD45.2
+) failed to 
repopulate in lethally irradiated B6-LY5.2/Cr host mice 
(CD45.1
+CD45.2
). n = 4. (G) Competitive repopulation 
was performed using bone marrow cells from 8-mo-old 
DNA-PKcs
/  and  age-matched  wild-type  mice.  DNA-
PKcs
/ HSCs (CD45.1
CD45.2
+) showed reduced re-
populating potential. n = 4. Error bars represent SD.JCB • VOLUME 193 • NUMBER 2 • 2011   300
bone marrow (Fig. 5 F) but restored to a lesser degree in the 
spleen (Fig. 5 G). Furthermore, even with the loss of a single 
p53 gene, the numbers of B cells were partially rescued. There 
were very few B220
+IgM
+ mature B cells in the 3A/p53
+/+ bone 
marrow, but these cells were clearly detectable in 3A/p53
/ 
mice  (Fig.  S4  C). Thus,  in  contrast  to  DNA-PKcs–deficient 
SCID mice in which loss of p53 does not rescue B cell develop-
ment (Nacht et al., 1996), there is partial rescue of B lympho-
cytes  in  3A/p53
/  mice. This  also  suggests  that  the V(D)J 
recombination defect in DNA-PKcs
3A/3A mice is less severe than 
in the complete absence of DNA-PKcs.
Increase of genotoxic stress in the 
intestinal crypt and epidermis
In addition to HSC loss, elevation of the p53-dependent geno-
toxic stress response in DNA-PKcs
3A/3A mice was also evident 
in the intestinal crypt and epidermis. The intestinal crypt is the 
proliferation  compartment  and  contains  intestine  stem  cells, 
which give rise to different intestine epithelial cells for intesti-
nal homeostasis maintenance. Immunohistological analysis re-
vealed that a significant increase of TUNEL-positive cells was 
found in the intestinal crypt of DNA-PKcs
3A/3A mice and that the 
p53-null mutation alleviated the defect completely (Fig. 6 A). Skin 
hyperpigmentation  is  another  example  of  a  p53-dependent 
stress response (McGowan et al., 2008) and can be found in the 
footpad and tail of DNA-PKcs
3A/3A mice (Fig. 6, B and C). As 
expected, the hyperpigmentation phenotype is completely re-
versed in 3A/p53
/ mice. Footpad hyperpigmentation became 
apparent in DNA-PKcs
3A/3A mice as early as 1 wk after birth and 
increase of Annexin V staining was also confirmed in freshly 
isolated  fetal  liver  LSK  cells  from  DNA-PKcs
3A/3A  embryos 
(Fig. 5 B), suggesting that HSC loss in DNA-PKcs
3A/3A mice is 
likely caused by excessive apoptotic cell death.
Loss of p53 mitigates the stem cell  
failure and promotes survival in  
DNA-PKcs
3A/3A mice
To examine whether HSC loss is caused by p53-mediated apop-
totic response, DNA-PKcs
3A mice were crossed with p53-null 
mutant mice. Loss of both p53 alleles doubled the life span of 
homozygotic DNA-PKcs
3A/3A mice (abbreviated as 3A; Fig. 5 C) 
and restored long-term HSCs (Lin
Sca-1
+c-Kit
+Flt3
CD34
) in 
DNA-PKcs
3A/3A mice (Fig. 5 D). Strikingly, loss of a single copy 
of p53 also prolonged the survival of 3A/p53
+/ mice. In a cohort 
of 22 3A/p53
+/ mice, 50% survived beyond 8 wk, which is 
significantly longer (P < 0.001) than the survival of 3A mice. 
Despite the enhanced survival, there was still a major depletion 
of bone marrow stem cells in 3A/p53
+/ mice. We estimate from 
two femur bones that there are 4.2 × 10
3 LSK cells in 3A/p53
+/ 
mice compared with 2.9 × 10
5 LSK cells in wild-type mice.
In addition to life-span extension, a p53-null mutation 
also  alleviated  the  developmental  defect  of  lymphocytes  in 
DNA-PKcs
3A/3A mice. Thymocyte cell numbers were partially 
rescued (60% of wild-type mice) in 3A/p53
/ mice but not in 
3A/p53
+/ mice (Fig. 5 E), and the distribution of CD4 versus 
CD8 cells was normalized in 3A/p53
/ thymocytes (Fig. S4 B). 
The rescue of B cell development was also obvious, as the num-
bers of B cells in 3A/p53
/ mice were completely normal in 
Figure 5.  Elevation of DNA damage and p53 signaling in 
DNA-PKcs
3A/3A mice. (A) -H2AX foci analysis with freshly 
isolated E12.5 fetal liver LSK cells. Cells were grouped 
into three categories based on the number of -H2AX foci: 
negative (zero foci/cell), positive (one to five foci/cell), 
and strong positive (more than five foci/cell). A total of   
50 cells were randomly selected from each genotype for 
analysis. Data represent two independent assays. Bar, 10 µm.   
(B)  Annexin  V  staining  of  freshly  isolated  LSKs  from 
E13.5 fetal livers (n ≥ 3 for each group). Lines indicate the 
means for each group. (C) Kaplan–Meier survival curves 
of DNA-PKcs
3A/3A mice (abbreviated as 3A) in different 
p53 genotype backgrounds. (D) Flow cytometric analysis 
of bone marrow (BM) HSCs in 2-wk-old mice. HSC loss, 
particularly  long-term  HSC  (Lin
Sca-1
+c-Kit
+Flt3
CD34
) 
loss in DNA-PKcs
3A/3A was completely rescued in the p53-
null background. (top) Boxes indicate the LSK cell gate 
(Lin
Sca-1
+c-Kit
+). (bottom) The numbers indicate the per-
centages of cell counts to total population in each quad-
rant. The lines separate the negative and the positive cell 
populations in each FACS analysis. (E–G) Null mutation of 
p53 rescues the numbers of T and B cells in DNA-PKcs
3A/3A 
mice. The numbers of thymocytes (E), bone marrow B cells 
(F), and splenic B cells (G) were determined from 2-wk-old 
wild-type mice as well as in DNA-PKcs
3A/3A mice with dif-
ferent p53 genotypes (n ≥ 3 for each group). Error bars 
represent SD.301 Hematopoietic failure in DNA-PKcs mutant mice • Zhang et al.
revealed that FANCD2 monoubiquitination was attenuated in 
DNA-PKcs
3A/3A MEFs in response to IR and MMC (Fig. 7 C and 
Fig. S5 D) but was not ablated as observed in FANCA
/ MEFs 
(Fig. S5 E). This attenuation is not likely caused by a reduced   
S-phase population in DNA-PKcs
3A/3A MEFs, as no clear differ-
ence exists in cell cycle redistribution between wild-type and 
DNA-PKcs
3A/3A MEFs (Fig. S5 C). Activated FANCD2 is re-
cruited to chromatin and forms nuclear foci where it facilitates 
HR and interstrand cross-link repair (Garcia-Higuera et al., 2001). 
In response to IR treatment, FANCD2 foci formation was de-
tected in wild-type cells as early as 20 min after irradiation 
(unpublished data), and the percentage of cells with FANCD2 
foci increases with time (Fig. 7 D). In contrast, FANCD2 foci in 
DNA-PKcs
3A/3A MEFs appeared with delayed kinetics, and the 
percentage of cells with foci was 50% of wild-type MEFs at 
various time points after IR. A similar defect was detected in the 
formation of Rad51 nuclear foci (Fig. S5 F), a prerequisite of 
HR-mediated DNA repair (Haaf et al., 1995). Formation of 
Rad51 foci was attenuated in DNA-PKcs
3A/3A MEFs but was en-
hanced in DNA-PKcs
/ MEFs, which is likely because of the 
elevation of HR activity in the absence of NHEJ (Allen et al., 
2002). Finally, we analyzed HR activity using the direct repeat 
(DR)–GFP reporter approach (Pierce et al., 1999). MEFs with a 
single integration of the DR-GFP reporter were transfected with 
an ISceI- glucocorticoid receptor (GR)–RFP construct to induce 
DSB formation and HR reaction (Soutoglou et al., 2007). Our 
result revealed that HR activity was attenuated in DNA-PKcs
3A/3A 
MEFs, and a significant portion of ISceI-GR-RFP–expressing 
(RFP
+) DNA-PKcs
3A/3A cells was GFP
 (no recombination) as 
compared with wild-type MEFs (Fig. 7 E). In contrast, HR activ-
ity was further enhanced in DNA-PKcs
/ MEFs because of a 
lack of NHEJ activity. The negative impact of the DNA-PKcs
3A 
mutant on the HR/FA responses thus provides an explanation for 
the phenotypical difference between DNA-PKcs
3A/3A mice and 
DNA-PKcs–null mice.
Discussion
The self-renewal property of HSCs and their ability to sustain 
long-term hematopoiesis require that genome integrity is strictly 
maintained (Kenyon and Gerson, 2007; Niedernhofer, 2008).   
It is well characterized that hematopoietic cells are highly sensi-
tive to radiation-induced DNA damage, and bone marrow aplasia 
is one of main causes for radiation-induced lethality. A recent 
study showed that HSCs, but not progenitor cells, are preferen-
tially killed by radiation, suggesting that HSCs are among the 
most sensitive cell types to DNA damage (Wang et al., 2006). 
HSCs in DNA repair-deficient individuals are highly suscepti-
ble to various kinds of genotoxic stresses. Genetically modified 
mouse models also revealed that defects in the DNA damage 
response result in the dysfunction of HSC maintenance. Hema-
topoietic failure with an early development of bone marrow hypo-
cellularity is manifested in mice with a hypomorphic mutation 
of Rad50 (Rad50
S/S; Bender et al., 2002) and mice knockout of 
ERCC1, a key factor in nucleotide excision repair and inter-
strand cross-link repair (Niedernhofer et al., 2004; Prasher et al., 
2005). Deficiency of ATM leads to elevated levels of oxidative 
was further darkened with age. In contrast, there was no footpad 
pigmentation  in  wild-type  and  heterozygotic  pups,  whereas 
mild footpad pigmentation could also be found in older (>2 mo) 
heterozygotic mice (unpublished data).
Hypersensitivity of DNA-PKcs
3A/3A MEFs 
to DNA cross-linking agents
DNA-PKcs
3A/3A MEFs exhibit a similar radiosensitivity to 
DNA-PKcs
/ MEFs and defective V(D)J recombination, yet 
only in DNA-PKcs
3A/3A mice is there a block in hematopoiesis 
and an activation of the p53 pathway. Thus, there are likely to be 
defects in addition to impaired NHEJ. To test this possibility, 
DNA-PKcs
3A/3A MEFs were subjected to different DNA dam-
age agents (Fig. 7 A and Fig. S5 A). Clonogenic survival analy-
ses  revealed  that  DNA-PKcs
3A/3A  MEFs  displayed  a  greater 
sensitivity toward replication stress inducers, including UV   
irradiation, camptothecin, and mitomycin C (MMC; Fig. 7 A). 
The most striking difference came from treatment with the DNA 
cross-linking agent MMC, as clonogenic survival of DNA-
PKcs
3A/3A MEFs was dramatically reduced, whereas hetero-
zygotic MEFs and, importantly, DNA-PKcs
/ MEFs were not 
affected. Furthermore, MMC treatment induced a significant 
increase in chromosome aberrations in DNA-PKcs
3A/3A MEFs 
(Fig. 7 B), among which radial structures were frequently ob-
served (Fig. S5 B).
Hypersensitivity  toward  DNA  cross-linking  agents  and 
bone marrow failure are the hallmarks of the inherited human 
disease FA. The repair of DNA interstrand cross-links is a com-
plex process that involves the FA complex and the HR pathway 
(Mirchandani and D’Andrea, 2006). To determine whether the 
FA pathway was affected, we analyzed the induction of FANCD2 
monoubiquitination in response to DNA damage. Immunoblotting 
Figure 6.  Activation of p53 in the intestinal crypt and epidermis in DNA-
PKcs
3A/3A mice. (A) Representative figures of a TUNEL assay. Increase of 
TUNEL-positive apoptotic cells (red) in the DNA-PKcs
3A/3A intestinal crypt 
(outlined with dashed lines). Nuclei were counterstained with DAPI (blue). 
Bar, 50 µm. (B) Skin hyperpigmentation is clearly distinguishable in the 
DNA-PKcs
3A/3A footpad and tail. (C) Hematoxylin and eosin staining of tail 
skin section. Massive melanin accumulated in the DNA-PKcs
3A/3A epidermis 
and was abolished in a p53-null background. Bar, 20 µm.JCB • VOLUME 193 • NUMBER 2 • 2011   302
DSBs are among the most dangerous types of DNA lesions 
and pose a great challenge to cellular survival and genome 
integrity maintenance. Multiple repair mechanisms, including 
NHEJ, HR, and additional backup pathways, have evolved to 
ensure that DSBs are promptly and properly eliminated from   
the genome. Outside V(D)J recombination events, endogenous 
DSBs occur primarily in the cycling cells though the conversion of 
single-strand lesions during replication (Vilenchik and Knudson, 
2003). From the standpoint of endogenous DSB production, 
we could assume that DNA-PK and its downstream NHEJ 
pathway, which is the predominant DSB repair mechanism in 
mammalian cells and is operational in all cell cycle phases, have 
a greater involvement in the replication-associated DNA damage 
response than we previously thought. However, it is not clear 
how DNA-PKcs and other factors of DSB repair are coordi-
nated in response to replicative stresses, particularly in the 
highly proliferative cell population. Our unexpected findings 
from the DNA-PKcs
3A mouse model provide strong evidence 
that the impact of DNA-PKcs, particularly its phosphorylation at 
the mouse Thr2605 cluster (human Thr2609), has a role beyond 
the NHEJ mechanism.
It recently became clear that the competition between the 
NHEJ and the HR/FA pathway has important biological signifi-
cance. For example, loss of the NHEJ factor 53BP1 alleviates 
stress and a progressive loss of the HSC pool with age (Ito   
et al., 2004). Similarly, NHEJ deficiency in Ku80 knockout 
mice  diminishes  HSC  self-renewal  capacity,  whereas  hypo-
morphic Lig4
Y288C mice display an age-dependent decrease in 
HSC numbers and bone marrow cellularity (Nijnik et al., 2007; 
Rossi et al., 2007). In contrast, HSC loss in DNA-PKcs
3A/3A 
mice occurs significantly earlier during embryonic develop-
ment,  which  resembles  Rad50
S/S  and  ERCC1
/  models, 
though it is not clear whether there is a functional overlap be-
tween the DNA-PKcs
3A mutant protein and these two DNA re-
pair factors in terms of HSC maintenance. On the other hand, 
complete DNA-PKcs deficiency leads to a decrease in HSC 
number (unpublished data) and repopulating ability in aged 
DNA-PKcs knockout mice. The distinct phenotypes in HSC 
maintenance between DNA-PKcs knockout and knockin mice 
is likely a result of their difference in DSB repair capacity, as 
DNA-PKcs
3A/3A cells are also defective in the HR/FA responses 
in addition to the diminished NHEJ activity. Thus, the com-
bined deficiency in DSB repair renders DNA-PKcs
3A/3A cells 
hypersensitive to MMC and other replication stress agents. It is 
conceivable that the HR/FA mechanism, but not the NHEJ, is 
essential for replication-associated DNA damage repair and is 
critical for the rapid expansion of HSC populations in develop-
ing fetal liver.
Figure 7.  Defect in multiple DNA repair pathways in DNA-
PKcs
3A/3A cells. (A) Clonogenic survival of SV40-transformed 
MEFs after UV irradiation, camptothecin (CPT), and mito-
mycin C (MMC). Representative data of three independent as-
says are shown. (B) Increase of MMC-induced chromosomal 
aberrations in DNA-PKcs
3A/3A MEFs from two independent 
experiments. (left) Percentages of MEFs harboring chromo-
somal aberrations with or without MMC treatment. (right) 
The average numbers of chromosome (Chre.) or chromatid 
(Chtid.) breaks and chromosomal fusions were calculated 
from ≥50 mitotic spreads of each genotype. (C) FANCD2 
monoubiquitination after IR treatment. Primary MEF cultures 
were subjected to 10 Gy of -ray and were harvested at 
the indicated time points for Western blotting. The ratios 
between mono- (L) and unubiquitinated (S) FANCD2 are 
shown. (D) FANCD2 nuclear foci formation after IR (5 Gy) 
treatment. Percentages of FANCD2 foci-positive cells (more 
than five foci) at different time points were analyzed from 
two  independent  assays.  Greater  than  200  cells  were 
counted for each time point and genotype. (E) Measurement 
of HR with a DR-GFP assay. MEFs with a single copy of the 
DR-GFP HR reporter were mock transfected or transfected 
with the ISceI-GR-RFP plasmid and were analyzed at 24 h. 
Lines divided the cells into three populations. The bottom 
left cell population is negative for both RFP and GFP; the 
bottom right cell population is only RFP positive. The top cell 
population is positive for both RFP and GFP. The numbers 
indicate percentages of cells in each gate. Recombination 
was determined by the fraction of GFP
+ cells among all 
GFP
+ and RFP
+ cells. Each point represents data from three 
individual clones. Error bars represent SD.303 Hematopoietic failure in DNA-PKcs mutant mice • Zhang et al.
to the loss of stem cells in bone marrow (Kennedy and D’Andrea, 
2005; Rani et al., 2008). It is interesting to note that the human 
dyskeratosis congenita syndrome, which is caused by telomerase 
mutations, also displays bone marrow failure and hyper skin pig-
mentation characters. Conversely, mice with combined mutations 
on telomerase and Pot1b, a component of the telomere-protecting 
shelterin complex, exhibit dyskeratosis congenita–like character-
istics, including bone marrow failure and footpad hyperpigmen-
tation (Hockemeyer et al., 2008; He et al., 2009). This similarity 
to DNA-PKcs
3A/3A mice suggests a common stress response 
among different congenital bone marrow failure diseases and war-
rants further investigation of DNA-PKcs phosphorylation on 
telomere maintenance.
Materials and methods
Construction of the targeting vector and generation of DNA-PKcs
3A/3A 
knockin mice
The 3A knockin targeting vector was constructed using a previously described 
self-excision gene-targeting approach (Bunting et al., 1999). The DNA-PKcs
3A 
mice were maintained in the mixed genetic background of 129× C57BL/6 
and were bred with p53-null mice in an FVB background. ES cell targeting 
and generation of chimeric mice were performed at the transgenic core facility 
at the University of Texas Southwestern Medical Center. All animal experimen-
tal protocols were approved by the Animal Care Committee of the University 
of Texas Southwestern Medical Center.
Clonogenic survival and chromosomal aberrations
Primary and SV40-transformed MEFs from E13.5 embryos were cultured in  
minimum essential medium supplemented with 10% fetal calf serum and peni-
cillin/streptomycin. MEFs were maintained in a 37°C humidified atmosphere 
with 3% O2 and 10% CO2. For clonogenic survival, SV40-transformed MEFs 
were treated with different doses of mutagens and were trypsinized/reseeded 
in appropriate numbers in 10-cm tissue-culture dishes for 7 d. For chromo-
somal aberrations, primary MEFs (passages 2–5) were incubated with   
40 nM MMC for 24 h and 0.1 mg/ml colcemid in the last 2 h.
Fluorescence-activated cell sorting and ex vivo expansion of HSCs
Thymus, bone marrow, or fetal liver single-cell suspensions were stained 
with the indicated antibodies and analyzed using either a FACSCalibur 
(BD) or LSRII (BD) flow cytometer (Huynh et al., 2008). HSCs were sorted 
using a flow cytometer (FACSAria; BD) essentially as previously described 
(Huynh et al., 2008). For apoptosis analysis, cell suspensions were stained 
with phycoerythrin-anti–Annexin V (BD). Ex vivo expansion of fetal liver 
HSCs was performed using a previously published protocol (Zhang and 
Lodish, 2004).
V(D)J recombination assay
D2:J1 coding joint junctions were PCR amplified from total thymocyte 
DNA using a nested amplification protocol. The PCR conditions and primer 
design are detailed in Fig. S2.
Bone marrow/HSC transplantation and competitive repopulating assay
Total bone marrow cells (5 × 10
5) or Lin
Sca-1
+c-Kit
+ cells (1,500–5,000) 
from wild-type littermates were injected into the retro-orbital plexus of 2- or 
3-wk-old DNA-PKcs
3A/3A mice without preconditioning. Competitive repopu-
lation was performed using wild-type, DNA-PKcs
3A/3A, or DNA-PKcs
/ 
cells (CD45.2 background), mixed with competitive bone marrow cells 
from B6-LY5.2/Cr mice (CD45.1 background), and injected into lethally ir-
radiated (5 Gy × 2) B6-LY5.2/Cr–recipient mice. 2 mo after injection, 
populations of CD45.1
+ and CD45.2
+ peripheral blood cells were ana-
lyzed by flow cytometry.
DR-GFP HR assay
SV40-transformed MEFs with single-copy incorporation of the DR-GFP re-
porter (Pierce et al., 1999) were transfected with the ISceI-GR-RFP plasmid 
(Addgene) and treated with 10 nM triamcinolone acetonide for 24 h fol-
lowed by flow cytometry analysis. HR activities were determined by the 
percentage  of  GFP
+RFP
+  double-positive  cells  among  all  ISceI-GR-RFP– 
expressing (RFP
+) cells.
the  hypersensitivity  of  HR-defective  Brca1  mutant  cells  to 
DNA-damaging agents and restores DSB repair by HR (Bouwman 
et al., 2010; Bunting et al., 2010). In addition, the FA pathway 
plays a critical role in eliminating toxic NHEJ; suppression of 
NHEJ alleviates the sensitivity of FA mutant cells to DNA cross- 
linking agents and facilitates error-free repair by HR (Adamo   
et al., 2010; Pace et al., 2010). Similarly, our data suggest that 
the DNA-PKcs
3A mutant protein interferes with the HR path-
way, which could explain the sensitivity to replication damage 
and the severity of hematopoietic failure.
We have previously reported that the human Thr2609 cluster 
is phosphorylated directly by the ATR kinase upon replication 
stress (Yajima et al., 2006). This ATR-dependent DNA-PKcs 
phosphorylation virtually facilitates processing of replication- 
associated DNA lesions through the HR/FA machinery. It is likely 
that, in such a repair process, the shift from error-prone end joining 
to faithful repair by the HR/FA is partially achieved by ATR- 
dependent DNA-PKcs phosphorylation. In support of this, a simi-
lar stem cell defect was observed in conditional ATR knockout 
mice (Ruzankina et al., 2007). It is not clear yet how DNA-PKcs 
phosphorylation at the Thr2609 cluster promotes HR/FA activities. 
One possible explanation is that Thr2609 cluster phosphorylation 
changes the conformation of DSB-bound DNA-PKcs and releases 
DSB ends to the HR/FA machineries (Meek et al., 2008).
The loss of HSCs in DNA-PKcs
3A/3A mice is primarily 
caused by p53-mediated apoptotic response, as the p53-null 
mutation reinstates HSC reserves in DNA-PKcs
3A/3A mice. In 
addition to HSC loss, elevation of genotoxic stress and p53 acti-
vation was found in other proliferating tissues as evident from 
intestinal crypt cell apoptosis and epidermal hyperpigmenta-
tion. These results reiterate that DNA-PKcs phosphorylation at 
the human Thr2609/mouse Thr2605 cluster is critical for repli-
cation stress response and the maintenance of tissue homeosta-
sis. The tissue-specific outcome of genotoxic stress imposed by 
the  DNA-PKcs
3A  mutant  protein  or  DNA-PKcs  dysfunction 
may depend on cell type–specific apoptosis/senescence and the 
compensation capacity from varied sizes of stem cell pools in 
different tissues and organs.
Gene mutations in the FA protein complex and HR compo-
nents have been indentified in human FA syndrome character-
ized by congenital bone marrow failure, short stature, abnormal 
skin pigmentation, reduced fertility, hypersensitivity toward DNA 
cross-link damages, and increased genomic instability (Moldovan 
and D’Andrea, 2009). The mechanism underlying the clinical 
findings of FA remains unclear, given the fact that none of the 
current mouse models for HR and FA systematically recapitu-
lated these pathophysiological changes. It is interesting to note 
that the DNA-PKcs
3A/3A mouse resembles human FA syndromes 
more than FA mouse models. The hallmarks of FA, including 
aplastic anemia, abnormal skin pigmentation, MMC sensitivity, 
and radial chromosome formation with MMC treatment, are all 
observed in DNA-PKcs
3A/3A mice, suggesting that, in human pa-
tients, FA mutations also likely affect the stem cell compartment 
during embryo development and activate p53, which generates 
pathological changes in multiple organs. Indeed, p53 has also 
been shown to be up-regulated in FA cells, and it has been specu-
lated that the p53-dependent apoptotic pathway may contribute JCB • VOLUME 193 • NUMBER 2 • 2011   304
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